Hydromorphone Quintian

Hydromorphone, the active ingredient in Hydromorphone Quintian, is an opioid analgesic presented as an injection for intravenous use. It treats severe acute pain, postoperative pain, and cancer‑related pain in adult patients.

GNH USA supplies Hydromorphone Quintian as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Hydromorphone is an opioid analgesic used to manage severe pain conditions.

- Severe acute pain: provides rapid analgesia for intense, short‑term pain episodes. - Post‑operative pain: controls pain following surgical procedures. - Cancer‑related pain: alleviates persistent pain associated with malignant disease.

Hydromorphone may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects: - Nausea - Constipation - Drowsiness - Dizziness - Dry mouth - Sweating

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension - Anaphylactic reaction - Adrenal insufficiency - Seizures - Dependence or addiction

Careful assessment and monitoring are required when using Hydromorphone Quintian.

- Assess respiratory function: monitor patients with compromised breathing. - Evaluate renal/hepatic impairment: adjust monitoring as needed. - Review opioid tolerance: avoid use in opioid‑naïve individuals without careful titration. - Concomitant CNS depressants: use with caution due to additive sedation. - Store at ambient temperature: keep in original packaging, protect from light and moisture.

Hydromorphone can interact with several medication classes, requiring vigilance.

Major Interactions (Avoid): - Other opioids: risk of profound respiratory depression. - Benzodiazepines or barbiturates: additive central nervous system depression. - MAO inhibitors: may cause severe hypotension or serotonin syndrome. - Strong CYP3A4 inhibitors (e.g., ketoconazole): increase hydromorphone plasma concentrations.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): may reduce analgesic effect. - Anticholinergic agents: may exacerbate constipation. - Diuretics: can enhance hypotensive response. - Selective serotonin reuptake inhibitors: monitor for serotonin syndrome.